Abstract
Cancer Biotherapy and Radiopharmaceuticals
officially retracts the article entitled, “Tectonic 1 Is a Key Regulator of Cell Proliferation in Pancreatic Cancer,” by Shiyong Zhao, Xuedong Chen, Ming Wan, Xingming Jiang, Chunlong Li, Yunfu Cui, and Pengcheng Kang, (Cancer Biother Radiopharm 2016;31(1):7–13; doi: 10.1089/cbr.2014.1778) due to incorrectly attributed or identified sequences. Several figures and text within the methods section are strikingly similar to those in other publications1–3 and suggests that same party prepared these papers for entirely different author sets.
The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves.
References
1. Wang Z, Xu D, Gao Y, et al. Immature colon carcinoma transcript 1 is essential for prostate cancer cell viability and proliferation. Cancer Biother Radiopharm 2015;30(7):278–284; doi: 10.1089/cbr.2014.1728.
2. Zhang C, Zhang T, Song E, et al. Ribosomal protein S15A augments human osteosarcoma xell proliferation in vitro. Cancer Biother Radiopharm 2018;29(10):451–456; doi: 10.1089/cbr.2014.1698.
3. Wang H, Wang B, Zhu W, et al. Lentivirus-nediated knockdown of myosin VI inhibits cell proliferation of breast cancer cell. Cancer Biother Radiopharm 2015;30(8):330–335; doi: 10.1089/cbr.2014.1759.
Get full access to this article
View all access options for this article.
